PGS Testing: How Main Line Fertility Supports Your Family-Building Journey
When you’re pursuing IVF, every detail matters, including the ability to test embryos for chromosomal abnormalities before transfer. Preimplantation Genetic Screening (PGS), also known as Preimplantation Genetic Testing for Aneuploidy (PGT-A), is a powerful tool that helps identify embryos with the correct number of chromosomes.
Why is this important? Embryos with abnormal chromosome counts often fail to implant or may lead to miscarriage. By testing embryos before transfer, PGS can:
- Increase the chance of a successful pregnancy by selecting chromosomally normal embryos.
- Reduce the risk of miscarriage by avoiding embryos with chromosomal abnormalities.
- Shorten time to pregnancy by prioritizing the healthiest embryos first.
- Provide peace of mind by offering clearer answers during the IVF process.
While some fertility centers limit the number of PGS cases they accept each month, Main Line Fertility provides uncapped, flexible scheduling. That means:
- Faster access. No waiting list or monthly cap.
- More flexibility. You and your physician can plan your cycle around what’s best for you, not what’s available.
- Greater peace of mind. Every patient has an equal opportunity to pursue the testing they need.
At Main Line Fertility, we believe patients shouldn’t face unnecessary barriers when it comes to their care. By offering access to PGS testing, we’re helping families move forward with confidence and clarity. If you’re considering IVF, or if you’ve heard about waitlists for genetic testing at other clinics, know that at MLF you’ll have seamless access to the latest advancements.